Gulf International Bank UK Ltd lowered its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 5.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 182,497 shares of the company’s stock after selling 10,300 shares during the period. Gulf International Bank UK Ltd’s holdings in Express Scripts were worth $13,621,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of ESRX. Somerset Trust Co raised its holdings in shares of Express Scripts by 23.1% during the 4th quarter. Somerset Trust Co now owns 28,505 shares of the company’s stock valued at $2,128,000 after purchasing an additional 5,346 shares in the last quarter. National Pension Service raised its holdings in shares of Express Scripts by 4.4% during the 4th quarter. National Pension Service now owns 556,473 shares of the company’s stock valued at $41,535,000 after purchasing an additional 23,364 shares in the last quarter. Bank of Montreal Can raised its holdings in shares of Express Scripts by 20.1% during the 4th quarter. Bank of Montreal Can now owns 794,395 shares of the company’s stock valued at $59,293,000 after purchasing an additional 132,758 shares in the last quarter. Convergence Investment Partners LLC raised its holdings in shares of Express Scripts by 7.0% during the 4th quarter. Convergence Investment Partners LLC now owns 53,526 shares of the company’s stock valued at $3,995,000 after purchasing an additional 3,502 shares in the last quarter. Finally, Oliver Luxxe Assets LLC bought a new position in shares of Express Scripts during the 4th quarter valued at $3,484,000. 88.21% of the stock is owned by institutional investors.
Express Scripts Holding (ESRX) traded down $0.46 during trading hours on Wednesday, hitting $80.41. 4,313,200 shares of the stock traded hands, compared to its average volume of 3,998,920. Express Scripts Holding has a one year low of $55.80 and a one year high of $81.75. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market cap of $45,540.00, a P/E ratio of 13.36, a price-to-earnings-growth ratio of 0.90 and a beta of 0.87.
Express Scripts announced that its Board of Directors has authorized a stock repurchase plan on Monday, December 18th that allows the company to buyback 45,000,000 outstanding shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.
In other news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now owns 87,400 shares in the company, valued at $6,124,992. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,644 shares of company stock worth $1,289,609. Insiders own 0.68% of the company’s stock.
A number of research firms have recently weighed in on ESRX. SunTrust Banks set a $82.00 price target on shares of Express Scripts and gave the company a “buy” rating in a report on Thursday, December 14th. Jefferies Group restated a “buy” rating on shares of Express Scripts in a report on Thursday, October 26th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a report on Monday, October 16th. Royal Bank of Canada set a $68.00 target price on shares of Express Scripts and gave the stock a “hold” rating in a report on Friday, December 15th. Finally, Evercore ISI initiated coverage on shares of Express Scripts in a report on Thursday, January 4th. They issued an “in-line” rating and a $78.00 target price on the stock. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $77.09.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.